Aude Ambresin

1.7k total citations
67 papers, 1.3k citations indexed

About

Aude Ambresin is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Aude Ambresin has authored 67 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Ophthalmology, 34 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Molecular Biology. Recurrent topics in Aude Ambresin's work include Retinal Diseases and Treatments (48 papers), Retinal and Optic Conditions (32 papers) and Retinal Imaging and Analysis (27 papers). Aude Ambresin is often cited by papers focused on Retinal Diseases and Treatments (48 papers), Retinal and Optic Conditions (32 papers) and Retinal Imaging and Analysis (27 papers). Aude Ambresin collaborates with scholars based in Switzerland, France and United States. Aude Ambresin's co-authors include Irmela Mantel, André Mermoud, Tarek Shaarawy, Léonidas Zografos, Ali Dirani, Lazaros Konstantinidis, Thomas J. Wolfensberger, Jean‐Antoine Pournaras, Alexandre Matet and Francine Béhar‐Cohen and has published in prestigious journals such as The American Journal of Human Genetics, American Journal of Ophthalmology and Investigative Ophthalmology & Visual Science.

In The Last Decade

Aude Ambresin

59 papers receiving 1.2k citations

Peers

Aude Ambresin
Maria‐Andreea Gamulescu Germany
Laura Dell’Arti Italy
Jean‐Antoine Pournaras Switzerland
Anoush Shahidzadeh United States
Maria Pefkianaki United Kingdom
Margriet M. de Vries Netherlands
Ignazio Maria Vallone Italy
Jean‐Christophe Zech France
Mari Ueki Japan
Shunsuke Hirose Japan
Maria‐Andreea Gamulescu Germany
Aude Ambresin
Citations per year, relative to Aude Ambresin Aude Ambresin (= 1×) peers Maria‐Andreea Gamulescu

Countries citing papers authored by Aude Ambresin

Since Specialization
Citations

This map shows the geographic impact of Aude Ambresin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aude Ambresin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aude Ambresin more than expected).

Fields of papers citing papers by Aude Ambresin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aude Ambresin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aude Ambresin. The network helps show where Aude Ambresin may publish in the future.

Co-authorship network of co-authors of Aude Ambresin

This figure shows the co-authorship network connecting the top 25 collaborators of Aude Ambresin. A scholar is included among the top collaborators of Aude Ambresin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aude Ambresin. Aude Ambresin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Somfai, Gábor Márk, Christoph Tappeiner, Katja Hatz, et al.. (2024). Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema—A Swiss Cohort Study. Pharmaceuticals. 17(9). 1235–1235. 1 indexed citations
2.
3.
Ambresin, Aude, et al.. (2023). Preventive Inflammation Management with Steroids before Retreatment with Anti-VEGF after Severe Inflammation due to Brolucizumab. Klinische Monatsblätter für Augenheilkunde. 240(4). 556–562.
4.
Mantel, Irmela, Aude Ambresin, Christoph Tappeiner, et al.. (2023). Intravitreal Dexamethasone as a Rescue for Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration with Persistent Disease Activity and High Treatment Demand. Journal of Ocular Pharmacology and Therapeutics. 40(6). 361–369. 1 indexed citations
5.
6.
Ambresin, Aude, et al.. (2022). Six Cases of Retinal Vascular Anomalies after Coronavirus Disease 2019: A Case Series. Klinische Monatsblätter für Augenheilkunde. 239(4). 537–544. 1 indexed citations
7.
Papasavvas, Ioannis, et al.. (2021). Prediction of Postoperative Visual Outcome in Patients with Idiopathic Epiretinal Membrane. Ophthalmologica. 244(6). 535–542.
8.
Ambresin, Aude, et al.. (2021). Non-immediate drug hypersensitivity reactions secondary to intravitreal anti-vascular endothelial growth factors. Graefe s Archive for Clinical and Experimental Ophthalmology. 260(3). 1005–1014. 3 indexed citations
9.
10.
11.
Matet, Alexandre, Alejandra Daruich, Ali Dirani, Aude Ambresin, & Francine Béhar‐Cohen. (2016). Macular Telangiectasia Type 1: Capillary Density and Microvascular Abnormalities Assessed by Optical Coherence Tomography Angiography. American Journal of Ophthalmology. 167. 18–30. 32 indexed citations
12.
Dirani, Ali, et al.. (2015). Risk factors and choroidal changes in patients with unilateral versus bilateral chronic active CSCR. Investigative Ophthalmology & Visual Science. 56(7). 3718–3718. 1 indexed citations
13.
Mariani, Alessandro, et al.. (2011). Characteristics of eyes with secondary loss of visual acuity receiving variable dosing ranibizumab for neovascular age-related macular degeneration. Graefe s Archive for Clinical and Experimental Ophthalmology. 249(11). 1635–1642. 36 indexed citations
14.
Konstantinidis, Lazaros, Aude Ambresin, Léonidas Zografos, & Irmela Mantel. (2009). Retinal pigment epithelium tears after intravitreal injection of ranibizumab for predominantly classic neovascular membranes secondary to age‐related macular degeneration. Acta Ophthalmologica. 88(7). 736–741. 32 indexed citations
15.
Polok, Bozena, Pascal Escher, Aude Ambresin, et al.. (2009). Mutations in CNNM4 Cause Recessive Cone-Rod Dystrophy with Amelogenesis Imperfecta. The American Journal of Human Genetics. 84(2). 259–265. 72 indexed citations
16.
Nguyen, Christophe, et al.. (2008). Treatment of Central Retinal Vein Occlusion-Related Macular Edema with Intravitreal Bevacizumab (Avastin®): Preliminary Results. Klinische Monatsblätter für Augenheilkunde. 225(5). 397–400. 12 indexed citations
17.
Tran, Hoai Viet, Aude Ambresin, & Thomas J. Wolfensberger. (2007). Posterior Sub-Tenon Triamcinolone Injection for Macular Edema Associated With Retinal Vein Occlusion. Investigative Ophthalmology & Visual Science. 48(13). 1548–1548.
18.
Nessi, Franco, Yan Guex‐Crosier, Aude Ambresin, & Léonidas Zografos. (2004). Photodynamic Therapy with Verteporfin for Subfoveal Choroidal Neovascularization Secondary to Toxoplasmic Chorioretinal Scar. Klinische Monatsblätter für Augenheilkunde. 221(5). 371–373. 8 indexed citations
19.
Ambresin, Aude, V. Tao Tran, François Spertini, & Carl P. Herbort. (2002). Behçet’s disease in Western Switzerland: Epidemiology and analysis of ocular involvement. Ocular Immunology and Inflammation. 10(1). 53–63. 38 indexed citations
20.
Ambresin, Aude, et al.. (2001). Recurrent Transient Visual Loss After Deep Sclerectomy. Archives of Ophthalmology. 119(8). 1213–1213. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria‐Andreea Gamulescu Breakdown of academic impact, for papers by Laura Dell’Arti Breakdown of academic impact, for papers by Jean‐Antoine Pournaras Breakdown of academic impact, for papers by Anoush Shahidzadeh Breakdown of academic impact, for papers by Maria Pefkianaki Breakdown of academic impact, for papers by Margriet M. de Vries Breakdown of academic impact, for papers by Ignazio Maria Vallone Breakdown of academic impact, for papers by Jean‐Christophe Zech Breakdown of academic impact, for papers by Mari Ueki Breakdown of academic impact, for papers by Shunsuke Hirose
Rankless by CCL
2026